February 2022

This month's OTC cases focus on cinnamon, chromium, glucose monitoring, and hypoglycemia.

How would you respond to these patient questions?

Institute for safe medication practices receives hundreds of reports of incorrect doses for children.

The FDA has approved Difelikefalin injection (Korsuva; Cara Therapeutics and Vifor Pharma) for the treatment of moderate-to-severe chronic kidney disease–associated pruritus in adults undergoing hemodialysis.

This month's OTC product news features Zinc Complex supplements, Similac 360 Total Care, and Flora Biome Live Probiotic.

Investigators used SC144, an FDA-approved molecule, to find a new pathway for a generation of nonhormonal contraceptives.

Alec Smith Insulin Affordability Act provides citizens with a long-term solution to diabetes expenditures.

Experts discuss women's health and health care during the COVID-19 pandemic as part of the Pharmacy Times® Pharmacy Focus webcast series.

Pharmacists can use these toolkits to answer questions and make clinical designs for medication therapy management services.

This month's generic product news features sertraline hydrochloride, calcitonin salmon injection, and arformoterol tartrate inhalation solution.

Tooth decay and loss, periodontal disease increase the risk of developing chronic conditions.

Process helps prevent errors for individuals with chronic disorders who often have a higher risk of drug-drug interactions.

Owner Amina Abubakar takes great pride in offering counseling services, education, and outreach, as well as vaccinations and compounding.

Pharmacists can play a critical role in this therapy, panelists in a recent Pharmacy Times® Peer Exchange say.

The claim is based on requested exemption from administering immunizations because of "needle phobia."

New analysis shows the substitution would cut costs by $600 million in the United States annually.

Increasing physical activities and reducing caloric intake isn’t always enough to conquer obesity.

Taking appropriate doses of vitamins and minerals may aid in lowering the risk of cardiovascular disease.

Lack of immediate results, cultural barriers, and high costs lead many to gamble with their cardiovascular health, study results show.

Pay for outcomes is here to stay. What therapeutic end points to evaluate success are on the horizon?

After almost 2 years of attending conferences virtually, the Pharmacy Times editorial team is getting back on the road again.